- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1550-7416
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim ; volume:20 ; number:5 ; day:15 ; month:8 ; year:2018 ; pages:1-14 ; date:9.2018
The AAPS journal / American Association of Pharmaceutical Scientists ; 20, Heft 5 (15.8.2018), 1-14, 9.2018
- Creator
-
Brekkan, Ari
- Contributor
-
Lopez-Lazaro, Luis
Yngman, Gunnar
Plan, Elodie L.
Acharya, Chayan
Hooker, Andrew C.
Kankanwadi, Suresh
Karlsson, Mats O.
SpringerLink (Online service)
- DOI
-
10.1208/s12248-018-0249-y
- URN
-
urn:nbn:de:101:1-2018102512145893769921
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Brekkan, Ari
- Lopez-Lazaro, Luis
- Yngman, Gunnar
- Plan, Elodie L.
- Acharya, Chayan
- Hooker, Andrew C.
- Kankanwadi, Suresh
- Karlsson, Mats O.
- SpringerLink (Online service)
Other Objects (12)
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria
Population Pharmacokinetic and Pharmacodynamic Modeling of Artemisinin Resistance in Southeast Asia
Optimal designs for composed models in pharmacokinetic-pharmacodynamic experiments
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
Automated optimal glycaemic control using a physiology based pharmacokinetic, pharmacodynamic model
Population Pharmacokinetic and Pharmacodynamic Modeling of Fesoterodine in Pediatric Patients with Neurogenic Detrusor Overactivity
Population pharmacokinetic and pharmacodynamic modelling of NS2330 and its major metabolite in Alzheimer's disease
Population pharmacokinetic/pharmacodynamic analysis of lopinavir and ritonavir in subjects receiving the tablet formulation
Population pharmacokinetic, pharmacodynamic and efficacy modeling of SB12 (proposed eculizumab biosimilar) and reference eculizumab
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria
Population Pharmacokinetic and Pharmacodynamic Modeling of Artemisinin Resistance in Southeast Asia
Optimal designs for composed models in pharmacokinetic-pharmacodynamic experiments
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
Automated optimal glycaemic control using a physiology based pharmacokinetic, pharmacodynamic model
Population Pharmacokinetic and Pharmacodynamic Modeling of Fesoterodine in Pediatric Patients with Neurogenic Detrusor Overactivity
Population pharmacokinetic and pharmacodynamic modelling of NS2330 and its major metabolite in Alzheimer's disease
Population pharmacokinetic/pharmacodynamic analysis of lopinavir and ritonavir in subjects receiving the tablet formulation
Population pharmacokinetic, pharmacodynamic and efficacy modeling of SB12 (proposed eculizumab biosimilar) and reference eculizumab
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria
Population Pharmacokinetic and Pharmacodynamic Modeling of Artemisinin Resistance in Southeast Asia
Optimal designs for composed models in pharmacokinetic-pharmacodynamic experiments
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
Automated optimal glycaemic control using a physiology based pharmacokinetic, pharmacodynamic model
Population Pharmacokinetic and Pharmacodynamic Modeling of Fesoterodine in Pediatric Patients with Neurogenic Detrusor Overactivity
Population pharmacokinetic and pharmacodynamic modelling of NS2330 and its major metabolite in Alzheimer's disease
Population pharmacokinetic/pharmacodynamic analysis of lopinavir and ritonavir in subjects receiving the tablet formulation